Article
Targeting mutant NRAS signaling pathways in melanoma.
Pharmacological research - 1 May 2016
Vu Ha Linh, Aplin Andrew E
Abstract excerpt
Cutaneous melanoma is a devastating form of skin cancer and its incidence is increasing faster than any other preventable cancer in the United States. The mutant NRAS subset of melanoma is more aggressive and associated with poorer outcomes compared to non-NRAS mutant melanoma. The aggressive nature and complex molecular signaling conferred by this transformation has evaded clinically effective treatment options....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
